<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport to Present its FY2015 Results and Business Update at the 2015 Marcum Microcap Conference

May 7, 2015

Lake Forest, CA, May 7, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal husbandry and reproductive medicine, announced today that its Chief Executive Officer, Jerrell Shelton, is scheduled to present at the 2015 Marcum MicroCap Conference at the Grand Hyatt in New York City on Thursday, May 28, 2015 at 9:30 a.m. EDT.

Read More


Tags: Frozen Shipping, 24/7 Support, Marcum, Cold Chain Logistics

Cryoport Supports NeoStem’s Intus Study for the Treatment of Metastatic Melanoma

April 29, 2015

Lake Forest, CA, April 29, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is supporting NeoStem, Inc.’s (NASDAQ: NBS) Intus Study to evaluate its lead cancer immunotherapy, NBS20, for the treatment of metastatic melanoma.

Read More


Tags: Frozen Shipping, Biopharmaceutical Cold Chain, NeoStem, Metastatic melanoma, Intus Study

Cryoport has Been Engaged by Roslin Cells for Logistics Support of Roslin’s iPSC service

March 31, 2015

Lake Forest, CA, March 31, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom in support of Roslin’s induced pluripotent stem cell  (iPSC) reprogramming service.

Read More


Tags: Frozen Shipping, Cancer, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News, Roslin, iPSC, pluripotent stem cell, reprogramming

COMBIMATRIX SELECTS CRYOPORT AS LOGISTICS PARTNER FOR THE DISTRIBUTION OF ITS NEW GENETIC SCREENING SERVICE

March 24, 2015

IRVINE, California, and LAKE FOREST, California, March XX, 2015 – CombiMatrix Corporation (NASDAQ: CBMX) and Cryoport, Inc. (OTCBB: CYRX), today announced CombiMatrix has selected Cryoport as its cryogenic logistics partner for the distribution of its new CombiPGS™ genetic screening test.

Read More


Tags: Frozen Shipping, Cancer, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News, Combimatrix

Cryoport Introduces New Tamper-Proof Lock on its Cryoport Express® Shippers for Animal Husbandry

March 18, 2015

Lake Forest, CA, March 18, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company introduced a new tamper-proof lock on its Cryoport Express® Shippers for exclusive use in the global animal husbandry market.

Read More


Tags: Frozen Shipping, Tamper-proof lock, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News

Cryoport Co-Sponsors the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day

March 11, 2015

Lake Forest, CA, March 11, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City.

Read More


Tags: Frozen Shipping, frozen shipping solution, Alliance for Regenerative Medicine, Cold Chain Logistics, Press Releases, Dry Shipper, News

Broekman Logistics to Support Expansion of Cryoport’s Growing Client Base in Asia

March 5, 2015

LAKE FOREST, CA – March 5, 2015 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that Broekman Logistics will support Cyroport’s Operations Center in Singapore, responding to Cryoport’s rapidly expanding client base in Asia. Broekman currently supports Cryoport’s European Operations Center, ensuring a seamless faciliation of Cryoport’s solutions for global life sciences clients.

Read More


Tags: Frozen Shipping, Broekman, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News

Cryoport Inc. Expands Support of Fred Hutchinson Cancer Research Center’s Clinical Research Division

March 3, 2015

Lake Forest, CA, March 3, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the expansion of its relationship with Fred Hutchinson Cancer Research Centers’ (“Fred Hutch”) Clinical Research Division with the inclusion of additional labs to be supported by Cryoport’s validated cryogenic logistics solutions for its cell-based therapies.

Read More


Tags: Frozen Shipping, Cancer, Fred Hutchinson Cancer Research Center, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News

Cryoport Provides Logistics Solution and Services for Kite Pharma’s Lead Clinical Program in Cancer Immunotherapy

February 24, 2015

Read More


Tags: Frozen Shipping, Cancer, Kite Pharma, Immunotherapy, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News

Cryoport and Sanaria Expand Logistics Partnership Supporting Malaria Vaccines

February 23, 2015

Lake Forest, CA, February 23, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is enhancing its cryogenic logistics support of its Sanaria partnership, which includes Sanaria’s production of malaria vaccine as well as its research and development efforts.

Read More


Tags: Frozen Shipping, Sanaria, malaria, vaccine, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, News